'Pharma Bro' Martin Shkreli to stay behind bars, loses appeal of conviction

A federal appeals court upheld the conviction and seven-year prison term of Martin Shkreli, the pharmaceutical executive known as "Pharma Bro," for defrauding investors in his hedge funds and conspiring to manipulate the stock of Retrophin Inc, a biotechnology company he ran.

from Reuters: U.S. https://ift.tt/2XXQUWH